fbpx

We were deeply shocked to learn of the devastating earthquake in Japan and would like to express our sincere condolences to the victims of this earthquake. In these difficult times, we would like to express our deepest sympathy to you and your fellow human beings.

Our thoughts are with all those affected, their families and friends. May the strength of the community and the support of those around you give you comfort during this difficult time.

Dr. Dorothea Hofer
Jürgen Feldmeier
Dr. Andreas Oser

Weitere News

Fee increase of the European Patent Office as of 1 April 2024

The European Patent Office will increase most of its fees by an average of around 5% as of 1 April 2024. The fee increase will be significantly higher for the 3rd and 4th renewal fees, which will rise by almost 30%.
記事へ

52 years of consistency and still fit for the future – Prüfer und Partner welcomes the next generation of partners

With Dr. Susanne Sonnenhauser and Dr. Christian Gärtner, two very experienced colleagues from the Prüfer und Partner team are joining the management.
記事へ

Recent earthquake in Japan

We were deeply shocked to learn of the devastating earthquake in Japan and would like to express our sincere condolences to the victims of this earthquake. In these difficult times, we would like to express our deepest sympathy to you and your fellow human beings.
記事へ

Abolition of the 10-day notification fiction at the European Patent Office

In view of the digital age, in which documents will only be served electronically in the future, the European Patent Office will abolish its so-called 10-day fiction of service, which previously governed the calculation of time limits, as of November 1, 2023.
記事へ

Prüfer & Partner recognized in IAM Patent 1000 2023 für Patent Prosecution and Nullity

We are pleased to share that our firm Prüfer & Partner together with four of our intellectual property attorneys have been recognized for their outstanding work in patent prosecution and nullity in the newly published 2023 Edition of iam Patent 1000, one of the world’s leading rankings with regard to patent services providers.
記事へ

Prüfer Experts Listed as Best Lawyers of the Year 2023 by Handelsblatt

We are very pleased that our patent attorneys Dr. Dorothea Hofer, Mr. Jürgen Feldmeier as well as Dr. Andreas Oser are listed as beste Anwälte des Jahres 2023 (best attorneys of the year 2023) in the ranking published by Handelsblatt on June 16, 2023.
記事へ

PRÜFER & PARTNER is ranked again in “The Legal 500 – Germany 2023”

Prüfer & Partner mbB Patent- und Rechtsanwälte is again recognised for its outstanding performance in the current ranking of “The Legal 500 – Germany”. The firm is recommended in the areas of “Patent Law: Patent Attorneys: Patent Prosecution” and “Patent Law: Patent Attorneys: Litigation” and is thus listed among the best IP law firms in Germany.
記事へ

Plausibility – an unsolved problem in patent granting

The decision of the Enlarged Board of Appeal (GBK) of the European Patent Office (EPO) in the currently pending proceedings G2/21 is awaited with great excitement. This could have a significant impact on the future filing strategy of applicants, because at its core is the question of when an invention is “ready” to file.
記事へ

The European patent grows to 39 contracting states with the accession of Montenegro

On July 15, 2022, Montenegro completed the final step towards accession to the European Patent Convention (EPC) by depositing its instrument of accession and became the 39th member state of the European Patent Organization (EPO) on October 1, 2022.
記事へ

Amendments of regulations before the German Patent and Trade Mark Office (DPMA)

In the months of May and July 2022, some amendments relevant for practice before the DPMA will enter into force. The most important ones in brief are listed here.
記事へ

Dear Sir or Madam,

In view of the digital age, in which documents will only be served electronically in the future, the European Patent Office will abolish its so-called 10-day fiction of service, which previously governed the calculation of time limits, as of November 1, 2023.

With amended Rules 126(2) and 127(2) EPC, the current fiction of service, according to which a document is deemed to have been served on the tenth day after delivery to the postal service provider or – in the case of electronic service – on the tenth day after its transmission (“ten-day rule”), will no longer apply as of November 1, 2023. Instead, a new fiction of service will be introduced, according to which electronic (but also any postal) service will be deemed to have taken place on the date as shown of the document.

The amended service fiction is expected to lead to a simplification for users because it will bring the service rules of the EPC and the PCT more in line with each other.

Do you have any further questions on this topic?

Please contact us, we will be pleased to advise you!

Jürgen Feldmeier, LL.M

Other UPC-Updates

Fee increase of the European Patent Office as of 1 April 2024

The European Patent Office will increase most of its fees by an average of around 5% as of 1 April 2024. The fee increase will be significantly higher for the 3rd and 4th renewal fees, which will rise by almost 30%.
記事へ

52 years of consistency and still fit for the future – Prüfer und Partner welcomes the next generation of partners

With Dr. Susanne Sonnenhauser and Dr. Christian Gärtner, two very experienced colleagues from the Prüfer und Partner team are joining the management.
記事へ

Recent earthquake in Japan

We were deeply shocked to learn of the devastating earthquake in Japan and would like to express our sincere condolences to the victims of this earthquake. In these difficult times, we would like to express our deepest sympathy to you and your fellow human beings.
記事へ

Abolition of the 10-day notification fiction at the European Patent Office

In view of the digital age, in which documents will only be served electronically in the future, the European Patent Office will abolish its so-called 10-day fiction of service, which previously governed the calculation of time limits, as of November 1, 2023.
記事へ

Prüfer & Partner recognized in IAM Patent 1000 2023 für Patent Prosecution and Nullity

We are pleased to share that our firm Prüfer & Partner together with four of our intellectual property attorneys have been recognized for their outstanding work in patent prosecution and nullity in the newly published 2023 Edition of iam Patent 1000, one of the world’s leading rankings with regard to patent services providers.
記事へ

Prüfer Experts Listed as Best Lawyers of the Year 2023 by Handelsblatt

We are very pleased that our patent attorneys Dr. Dorothea Hofer, Mr. Jürgen Feldmeier as well as Dr. Andreas Oser are listed as beste Anwälte des Jahres 2023 (best attorneys of the year 2023) in the ranking published by Handelsblatt on June 16, 2023.
記事へ

PRÜFER & PARTNER is ranked again in “The Legal 500 – Germany 2023”

Prüfer & Partner mbB Patent- und Rechtsanwälte is again recognised for its outstanding performance in the current ranking of “The Legal 500 – Germany”. The firm is recommended in the areas of “Patent Law: Patent Attorneys: Patent Prosecution” and “Patent Law: Patent Attorneys: Litigation” and is thus listed among the best IP law firms in Germany.
記事へ

Plausibility – an unsolved problem in patent granting

The decision of the Enlarged Board of Appeal (GBK) of the European Patent Office (EPO) in the currently pending proceedings G2/21 is awaited with great excitement. This could have a significant impact on the future filing strategy of applicants, because at its core is the question of when an invention is “ready” to file.
記事へ

The European patent grows to 39 contracting states with the accession of Montenegro

On July 15, 2022, Montenegro completed the final step towards accession to the European Patent Convention (EPC) by depositing its instrument of accession and became the 39th member state of the European Patent Organization (EPO) on October 1, 2022.
記事へ

Amendments of regulations before the German Patent and Trade Mark Office (DPMA)

In the months of May and July 2022, some amendments relevant for practice before the DPMA will enter into force. The most important ones in brief are listed here.
記事へ

We are delighted to announce that our managing partner Dr. Dorothea Hofer has obtained the European Patent Litigation Certificate issued by the University of Maastricht in cooperation with the Academy of European Law (ERA) in Trier. This includes an extensive practical and theoretical training in the law underlying the Unified Patent Court (#UPC) and related fields of European law so that she is well prepared for representing clients in all proceedings before the Unified Patent Court.

Other UPC-Updates

UPCから見たクレーム解釈、事実の開示と立証の責任 – UPC_CoA_335/2023

UPCの最初の判決が下された。クレーム解釈、事実の開示と立証の責任、さらに進歩性の検討など、多くの議論がなされている問題に関するUPCの立場を知ることは、エキサイティングなことである。
記事へ

Comparison of opposition proceedings at the EPO and revocation actions at the UPC – advantages and disadvantages

Since the introduction of the Unified Patent Court (UPC) in June 2023, a new system for central attacking the validity of and thereby to nullify a European Patent has been introduced. If a European patent of concern is an EU Unitary Patent, or if a classically validated European patent was not opted out from the competence of the UPC, a central revocation action under the UPC now exists in parallel to an opposition before the European Patent Office (EPO). Therefore, the question arises: what are the pros and cons of challenging the validity either before the EPO or before the UPC? The present report provides some guidance and discusses the main advantages and disadvantages of each system – which eventually is a matter of strategic considerations whether and which advantage may prevail – be it costs, timing, speed of proceedings, and possibly other issues.
記事へ

Dr Dorothea Hofer has obtained the European Patent Litigation Certificate

We are delighted to announce that our managing partner Dr. Dorothea Hofer has obtained the European Patent Litigation Certificate issued by the University of Maastricht in cooperation with the Academy of European Law (ERA) in Trier. This includes an extensive practical and theoretical training in the law underlying the Unified Patent Court (#UPC) and related fields of European law so that she is well prepared for representing clients in all proceedings before the Unified Patent Court.
記事へ

Chances and Risks of the New European Unitary Patentand New Unified Patent Court – Part 3

Opposition proceedings before the European Patent Office (EPO) are an attractive forum for challenging patents; the procedure is virtually unrivaled worldwide in terms of value for money. The process is simple, streamlined and relatively inexpensive. The practice is well tested. However, there are restrictions and drawbacks – for example, a deadline of nine months after the grant date for submission, the long duration of the opposition and appeal proceedings, and strict rules for admitting evidence submitted late.
記事へ

Chances and Risks of the New European Unitary Patentand New Unified Patent Court – Part 2

During a seven-years transition phase, the jurisdiction of the future Unified Patent Court (UPC) can be declared inapplicable, by way of an opt-out request by the IP right holder, to a pending European patent application (“EP application”), to a granted European patent (“EP”), or to a supplementary protection certificate (“SPC”). This possibility was introduced to build confidence by users on the long run. If opted-out, disputes will then continue to be handled by national courts on a country-by-country basis. Once a European patent has been opted out, it is excluded from the jurisdiction of the UPC for its entire life.
記事へ

Chances and Risks of the New European Unitary Patentand New Unified Patent Court – Part 1

June 1, 2023 marks the beginning of a new era in European patent law: the new European Unitary Patent system entered into force, consisting of the Unitary Patent (UP) and the Unified Patent Court (UPC). 50 years after the introduction of the European Patent Convention and millions of European patents filed, this may be the most prominent change in European patent practice. The Unitary Patent adds as a third pillar to the classical European patents and the national patents. The Unified Patent Court will have an influence on both the unitary patent and the classical European patents as a modern and efficient litigation system.
記事へ

The Unified Patent Court will start on June 1, 2023

Years of planning finally become reality: The official starting signal has now been given! Germany ratified the Agreement on a Unified Patent Court (UPC) on February 17, 2023.
記事へ

Start of the Sunrise Period for Filing Opt-out Requests with the Unified Patent Court on March 1, 2023

According to the current schedule, the Unified Patent Court will start its work on June 1, 2023. The so-called sunrise period, during which opt-out requests can be filed with the Unified Patent Court for granted European patents or published European patent applications will start on March 1, 2023, according to the current planning of the Unified Patent Court.
記事へ

All good things are worth waiting for

“All good things are worth waiting for”. Now the time has finally come: The Unified Patent Court has announced on its website that it plans to commence operations on April 1, 2023.
記事へ

Roadmap and preparations for the EU Unitary Patent and EU Patent Court System

As previously reported, following ratification in Germany, the way is cleared for the European patent with unitary effect (EU unitary patent) and the Unified Patent Court (UPC). As a result of the deposit of the instrument of ratification by Austria on 18 January 2022, the “provisional application of the EPC/UPC” has now entered into force.
記事へ

(III) Comparison of Opposition Proceedings at the EPO and Nullity Proceedings at the UPC

Opposition proceedings before the European Patent Office (EPO) are an attractive forum for challenging patents; the procedure is virtually unrivaled worldwide in terms of value for money. The process is simple, streamlined and relatively inexpensive. The practice is well tested. However, there are restrictions and drawbacks – for example, a deadline of nine months after the grant date for submission, the long duration of the opposition and appeal proceedings, and strict rules for admitting evidence submitted late.

The UPC now offers a second chance by providing another forum for central revocation of a European patent throughout the territory of the UPC states. Moreover, revocation actions can be brought before the UPC at any time after grant, independently of opposition proceedings before the EPO. Therefore, it is indeed a (further) effective attack on the European patent, and even in case European opposition and appeal proceedings were already pending in parallel. In the German legal system, on the other hand, there is the restriction – besides the fact that it only acts against the German part of the European patent – that revocation proceedings are inadmissible as long as European opposition and appeal proceedings are still pending.

The opposition procedure at the EPO is essentially a written procedure with an oral hearing at the end; the oral hearing takes place before a three-member panel and may last a full day. The UPC follows a similar approach – a written procedure followed by an oral hearing. However, there is a tight timing in the invalidity proceedings before the UPC. The UPC requires the patent owner to file a response within two months (while the EPO sets a four-month deadline); then the plaintiff may file a reply to the response within two months, and the defendant (patent owner) may file a rejoinder to the reply within one month, limited to the points raised in the reply.

The faster procedure before the UPC may allow for tactics on the nullity plaintiff’s side that weren’t available before. This is because, whilst the plaintiff can prepare his facts and arguments (and potential counter-arguments) well in advance of lodging the action, pressure is put on the defendant (patent owner) with respect to time and effort. Therefore, an efficient interaction of the patent owner with his team of attorneys is important. If on the other hand the patent owner starts with an infringement action, pressure will rather lie on the side of the infringement defendant in case he seeks to raise a defence by counter-action of nullity; this is because the counter-action should then be lodged soon after the start of the infringement action for being considered during the infringement proceedings.

A difference is that filing an invalidity action at the UPC is more expensive than filing an opposition at the EPO: court fee amounts to 20 000 EURO, whereas at the EPO it is presently only 880 EURO. The costs at the UPC are comparable to filing a German nullity action – however with the difference that the decision is effective throughout the UPC territory.

Although the opposition divisions of the EPO could, in principle, order the parties to pay the costs, this very rarely happens in practice; the predominant rule is that each party bears its own costs. The UPC Rules of Procedure provide that a winning party is entitled to reimbursement of its costs insofar as these are reasonable and proportionate.

There is also a risk that matters before the UPC will become complicated if the validity of a European patent is challenged by a counterclaim to an infringement action. In opposition proceedings before the EPO, only the validity itself is examined – the EPO does not consider infringement at all.

However, there is also the possibility that the proceedings before the UPC are split into two – i.e. a bifurcated system like the one practiced in Germany – where infringement and the validity are decided separately by two different courts (the former by the Local Division, the latter by the Central Division).

While all isolated revocation actions are heard by a central chamber of the UPC, revocation counterclaims in response to infringement may instead be brought before the then competent local chamber of the UPC; however, it is at the discretion of the local chamber to refer the revocation counterclaim to the central chamber. Practice will show which principle – the one-track or the two-track procedure – will bring overall advantages before the UPC and possibly prevail in the long run.

As can be seen from this overview, there are similarities but also differences between the opposition procedure before the EPO and the nullity procedure before the UPC. Probably the most significant difference in practice is the relatively strict time regime foreseen for the proceedings before the UPC. This is especially true when the infringement and revocation counterclaims run concurrently and thus require effective and expeditious action by the parties and their representatives. However with the benefit of a decision within a short time.

Further to Part 1: (I) Introduction and Overview

Further to Part 2: (II) Strategic Considerations of using the new EU Court, or Opting out

Other UPC-Updates

UPCから見たクレーム解釈、事実の開示と立証の責任 – UPC_CoA_335/2023

UPCの最初の判決が下された。クレーム解釈、事実の開示と立証の責任、さらに進歩性の検討など、多くの議論がなされている問題に関するUPCの立場を知ることは、エキサイティングなことである。
記事へ

Comparison of opposition proceedings at the EPO and revocation actions at the UPC – advantages and disadvantages

Since the introduction of the Unified Patent Court (UPC) in June 2023, a new system for central attacking the validity of and thereby to nullify a European Patent has been introduced. If a European patent of concern is an EU Unitary Patent, or if a classically validated European patent was not opted out from the competence of the UPC, a central revocation action under the UPC now exists in parallel to an opposition before the European Patent Office (EPO). Therefore, the question arises: what are the pros and cons of challenging the validity either before the EPO or before the UPC? The present report provides some guidance and discusses the main advantages and disadvantages of each system – which eventually is a matter of strategic considerations whether and which advantage may prevail – be it costs, timing, speed of proceedings, and possibly other issues.
記事へ

Dr Dorothea Hofer has obtained the European Patent Litigation Certificate

We are delighted to announce that our managing partner Dr. Dorothea Hofer has obtained the European Patent Litigation Certificate issued by the University of Maastricht in cooperation with the Academy of European Law (ERA) in Trier. This includes an extensive practical and theoretical training in the law underlying the Unified Patent Court (#UPC) and related fields of European law so that she is well prepared for representing clients in all proceedings before the Unified Patent Court.
記事へ

Chances and Risks of the New European Unitary Patentand New Unified Patent Court – Part 3

Opposition proceedings before the European Patent Office (EPO) are an attractive forum for challenging patents; the procedure is virtually unrivaled worldwide in terms of value for money. The process is simple, streamlined and relatively inexpensive. The practice is well tested. However, there are restrictions and drawbacks – for example, a deadline of nine months after the grant date for submission, the long duration of the opposition and appeal proceedings, and strict rules for admitting evidence submitted late.
記事へ

Chances and Risks of the New European Unitary Patentand New Unified Patent Court – Part 2

During a seven-years transition phase, the jurisdiction of the future Unified Patent Court (UPC) can be declared inapplicable, by way of an opt-out request by the IP right holder, to a pending European patent application (“EP application”), to a granted European patent (“EP”), or to a supplementary protection certificate (“SPC”). This possibility was introduced to build confidence by users on the long run. If opted-out, disputes will then continue to be handled by national courts on a country-by-country basis. Once a European patent has been opted out, it is excluded from the jurisdiction of the UPC for its entire life.
記事へ

Chances and Risks of the New European Unitary Patentand New Unified Patent Court – Part 1

June 1, 2023 marks the beginning of a new era in European patent law: the new European Unitary Patent system entered into force, consisting of the Unitary Patent (UP) and the Unified Patent Court (UPC). 50 years after the introduction of the European Patent Convention and millions of European patents filed, this may be the most prominent change in European patent practice. The Unitary Patent adds as a third pillar to the classical European patents and the national patents. The Unified Patent Court will have an influence on both the unitary patent and the classical European patents as a modern and efficient litigation system.
記事へ

The Unified Patent Court will start on June 1, 2023

Years of planning finally become reality: The official starting signal has now been given! Germany ratified the Agreement on a Unified Patent Court (UPC) on February 17, 2023.
記事へ

Start of the Sunrise Period for Filing Opt-out Requests with the Unified Patent Court on March 1, 2023

According to the current schedule, the Unified Patent Court will start its work on June 1, 2023. The so-called sunrise period, during which opt-out requests can be filed with the Unified Patent Court for granted European patents or published European patent applications will start on March 1, 2023, according to the current planning of the Unified Patent Court.
記事へ

All good things are worth waiting for

“All good things are worth waiting for”. Now the time has finally come: The Unified Patent Court has announced on its website that it plans to commence operations on April 1, 2023.
記事へ

Roadmap and preparations for the EU Unitary Patent and EU Patent Court System

As previously reported, following ratification in Germany, the way is cleared for the European patent with unitary effect (EU unitary patent) and the Unified Patent Court (UPC). As a result of the deposit of the instrument of ratification by Austria on 18 January 2022, the “provisional application of the EPC/UPC” has now entered into force.
記事へ

(II) Strategic Considerations of using the new EU Court, or Opting out

During a seven-years transition phase, the jurisdiction of the future Unified Patent Court (UPC) can be declared inapplicable, by way of an opt-out request by the IP right holder, to a pending European patent application (“EP application”), to a granted European patent (“EP”), or to a supplementary protection certificate (“SPC”). This possibility was introduced to build confidence by users on the long run. If opted-out, disputes will then continue to be handled by national courts on a country-by-country basis. Once a European patent has been opted out, it is excluded from the jurisdiction of the UPC for its entire life.

Opt-outs are not possible for unitary patents.

Opt-out requests are free of official fees and can be filed by IP right owners or by representatives admitted to the UPC. To reduce costs, mass requests on the basis of lists is recommended, using software specially developed for this purpose to reduce administrative measures on the part of attorneys. It is important to ensure that the opt-out request correctly identifies all actual owners of IP rights; the owners entered in the EPO register may not currently be the correct ones. In case of doubt, it is advisable to compare the data with official registers, e.g. to detect changes or transfers of rights in the meantime. An originally undetected inaccuracy could still be objected years later in a legal dispute, and an originally invalid opt-out may lead to the undesired applicability of the UPC.

There is a time limitation for the opt-out request: if an action is received by the UPC, e.g. in the form of a revocation action, a subsequent opt-out has no effect. On the other hand, it may make sense – for example, if circumstances or strategy change, see considerations below – to make the opted-out EP patent later accessible to the UPC by withdrawing the opt-out (opt-back-in).

An opt-out for a divisional application is independent of that for the parent application.

Advantages and disadvantages of the UPC – what speaks for an opt-out, what against?

Numerous factors in general and in particular will influence the decision whether for certain patents the benefits of the UPC outweigh the disadvantages, or whether it is better to opt out.

The advantages and benefits of the UPC outweigh the disadvantages if the following objectives are pursued:

(1) A unitary decision allows enforcement in all participating (currently 17, likely more in the future) EU countries with a single infringement action. This advantage comes into play especially when acts of infringement take place in several countries. This advantage is limited when non-participating countries are involved, such as non-EU countries like the UK or Switzerland, where infringement proceedings might still have to be brought specifically. However, these adverse effects could be neutralized again, for example, if a number of UPC states are nevertheless affected or if the remaining national courts follow the UPC judgment, or if the UPC judgment favours a party settlement; due to the speedy procedure at the UPC, it can be expected that the UPC judgment will be available first.

(2) In addition to the corresponding procedural and substantive unification and simplification, the enforcement of patents in large parts of Europe is achieved at relatively lower costs. The winning party get its costs reimbursed at least partially. Some selected cost items of UPC proceedings are listed in Table 3 below.

(3) The duration of proceedings per instance is expected to be only 12-14 months from the initiation of the proceedings to the judgment.

(4) Patent owners usually get a free choice of an appropriate venue, especially if an active rather than passive/defensive strategy is pursued. It may be expected that the four German local courts of the UPC with their competence will have a high attraction especially for patent owners. The Munich based central court has received more competence: following withdrawal of the London central court, it will now decide on chemical cases, in addition to patents pertaining to the mechanical field already allocated previous.

(5) The UPC decides with the involvement of technical judges. This can and will probably help to clarify the facts, especially in the case of technically demanding patents. In line with this favourable new feature: European patent attorneys, in case of having an appropriate additional legal qualification are now admitted to represent as a single counsel at the UPC. Thus, with the additional technical competence on both the judge’s and the representative’s side, communications “at eye level” with this panel of judges can be expected – an important advantage especially in oral proceedings.

(6) The use of a uniform language, such as English as an international standard.

(7) The expected harmonization of Europe-wide dispute regulation. And thus the avoidance of poorly predictable, country-specific case law in national courts.

(8) Effective evidence-gathering procedures, such as inspections, are possible that may not be or only poorly available in a national court.

(9) In the case of contributory patent infringement, the UPC avoids weaknesses of some national legal systems that require a “double territoriality principle” (a contributory infringer can only be accused if both its supply of an essential element and the ultimately realized infringement of the claimed invention by someone else both occur in the territory of the same state). The UPC system, on the other hand, facilitates effective enforcement against both the supplier and the direct infringer, because it is sufficient that both delivery and direct infringement take place somewhere in the entire UPC territory. This is a clear strategic advantage, especially in the situation of pan-European supply chains that is frequently found today.

(10) The successful plaintiff recovers part of his legal costs if he wins the case. The amount of reimbursement is determined by reasonable costs of the party’s representative; it is capped depending on value of action (e.g. if value of action is 1 million, then up to 112,000 EUR may be reimbursed).

Table 3: Costs for 1st instance proceedings at the UPC

Type of Proceedings UPC court fees
 

Infringement

 

Fixed fee: 11,000 EUR

optionally plus value-based fee depending on
value of action, e.g.
500,000 EUR
1,000,000 EUR
5,000,000 EUR
additional fee
0 EUR
8,000 EUR
32,000 EUR
Nullity Fixed fee: 20,000 EUR
Preliminary injunction Fixed fee: 11,000 EUR

 

However, the UPC also carries risks and potentially leads to disadvantages, so that patent applicants and owners might be more inclined to classical patents and requesting opt-out:

(1) The main disadvantage is the risk that a central attack to validity is possible and can thus lead to total revocation in the entire UPC area with a single decision. The classical EP patent system, on the other hand, allows further strategic options even if validity could be denied only in one country but affirmed in another.

(2) A deadline of only 2 months to prepare and file a response to a nullity attack is quite short to react. Appropriate representation of the proprietor is important to ensure fast processing without delay, to make full use of the response term.

(3) An earlier national right (i.e. prior art according to Art. 54(3) EPC, which has an earlier priority in relation to the unitary patent in dispute, but was published after the priority/filing date of the patent in dispute) has novelty-destroying effect vis-à-vis the unitary patent in the entire UPC area. Whereas in the context of classical EP patents, the earlier right is novelty-destroying only in the same country and if the EP patent was validated there.

(4) A central attack on validity is also possible following or even in parallel with opposition proceedings at the EPO. A central revocation action is possible as an independent action or as an invalidity counterclaim during infringement proceedings.

(5) A lack of guidance from case law in the initial phase, as the UPC will need time to develop its case law and clarify the many unclear details of the new system.

Various factors thus play a role in the decision for or against an opt-out; the advantages and disadvantages of the new and the known systems must be weighed against each other, and a decision made from this for all or part of one’s own patent portfolio. If the benefits of effective, “Europe-wide” and relatively inexpensive litigation, the broader choice of forums or legal enforcement against several defendants – possibly linked via supply chains – are in the foreground, the advantages of the new UPC system could tip the balance. If, on the other hand, one fears centralized attacks on validity and thus the risk of a complete loss of the patent in one legal action, especially in the case of important patents, one will, as a precaution, tend to avoid the UPC and therefore favours opt out.

The development of case law on patent infringement cases as well as harmonization through the new UPC will help to make the right decision for one or the other system in the consideration of the individual case. Whereby a temporally staggered and differentiated strategy makes a good combination possible: by opting out, first wait for the legal development in a state of low risk of total revocation and observe the competitive situation; if the new UPC legal framework proves to be legally secure and its advantages in procedural questions are confirmed, or if patent infringements are acutely recognizable, then a change to the UPC system is possible by a simple request for withdrawal of the opt-out (opt back-in). However, this should be well considered, as a renewed opt-out is no longer possible after an opt-in change.

Ultimately, it is a decision for each individual case. Depending on the specific case, important considerations are in favour of the new UPC system:

  • The procedural steps of an infringed process patent are carried out in different European countries. Or supply chains of different European countries form a link between indirect and direct patent infringement: a market participant in one UPC country supplies an essential element, and a third party in another UPC country directly uses the claimed subject matter. Or cross-border enforcement in multiple countries is the primary goal. For such cases, the effective new court system is predestined.
  • The legal and/or procedural provisions at the UPC are more favourable than in national courts or have a positive effect on enforcement in individual cases. For example, exceptions such as the research and registration (Bolar) privilege may be applied more narrowly than is the case in Germany, for example. Or the possibilities for preserving evidence are more effective in the UPC system than in some national legal practices.
  • The main competitor is based in a country where the national courts are not patent-friendly, or where the judges are inexperienced in patent cases, or where the procedure for gathering evidence is inefficient.
  • The patent’s validity is certain and hence a central validity attack won’t be successful. Reasons for this may be: it has already successfully survived an invalidity proceeding, for example in an opposition at the European Patent Office (at least in the first instance); or prior to legal enforcement, an own search has not brought up any prior art more relevant than in the examination proceedings.
  • Statistically, there is a relatively higher probability that European patents will be declared invalid by national courts than in European opposition/appeal proceedings. It remains exciting to see whether the UPC will follow the EPO’s case law rather than the different national case law in questions of validity for harmonization reasons, and thus whether the patent in suit may have a better chance of success before the UPC than in national nullity proceedings. If, as is so often the case, the decisive question of inventive step is at stake, the more patentee-friendly ruling practice could become established if the “problem-solution approach” customary at the EPO is applied. Also in the case of so-called “selection inventions”, one will want to choose a ruling practice close to the EPO and thus rather a Europe-harmonized system.
  • On the other hand, special exceptional situations, e.g. when the practice of the EPO appears to be rather critical of the patent proprietor – for example in the case of problematic claim amendments during the examination procedure without a clear basis of disclosure (added mater issues) – may speak for a preference of national courts, whose practice in questions of disclosure of origin is usually less strict.
  • Among the judiciary of the Unified Patent Court are many judges from national patent litigation chambers that have previously ruled on patent infringement. As far as the question of patent infringement is concerned, a large part of the previous (also national) case law will be taken over by the Unified Patent Court. This is another reason to choose one of the four German local chambers in Düsseldorf, Munich, Mannheim or Hamburg as the forum for the UPC location, as their judicial practice suggests a rather patent-owner-friendly attitude.
  • Another reason for choosing the UPC as a forum is the expectation that technical expertise will be given greater weight due to the presence of technical judges on the bench and the admittance of specially qualified European patent attorneys to conduct the parties’ proceedings.

Importantly, the decision phase in favour or against (opt-out) the UPC goes beyond the initial sunrise period, as it should also be carried out on an ongoing basis for current and future EP applications and granted patents.

The decision as to whether the European patent will ultimately take the form of a unitary patent or whether it will be validated nationally should thus also take into account the aspects of the desired court system. Only validated EP-patents can be opted out. If the applicant on the other hand decides in favour of the unitary patent, an opt-out is not possible; the UPC system is then mandatory. An opt-out request made earlier will then become ineffective. In this respect, there is a connection between the decisions for or against unitary patent, and for or against UPC. That is, the decision for or against a unitary patent – especially at the time of patent grant – should already take into account possible infringement and validity issues that may arise in future. Consideration should also be given to where the current and future relevant markets are, where infringement might occur, and whether cross-border enforcement would be desirable.

Applicants should also be aware of different filing strategies to mitigate the risks of the new system. For example, it may make sense to keep a divisional application pending as a fallback position for important European patent families. The parent patent can be validated nationally while the divisional application can go into the new system (or vice versa) to allow more flexibility in litigation strategy. It should also be noted that several European countries allow double protection, i.e. national patents may exist besides unitary patents, even if/insofar the claimed scope is the same.

Further to Part 1: (I) Introduction and Overview

Further to Part 3: (III) Comparison of Opposition Proceedings at the EPO and Nullity Proceedings at the UPC

Other UPC-Updates

UPCから見たクレーム解釈、事実の開示と立証の責任 – UPC_CoA_335/2023

UPCの最初の判決が下された。クレーム解釈、事実の開示と立証の責任、さらに進歩性の検討など、多くの議論がなされている問題に関するUPCの立場を知ることは、エキサイティングなことである。
記事へ

Comparison of opposition proceedings at the EPO and revocation actions at the UPC – advantages and disadvantages

Since the introduction of the Unified Patent Court (UPC) in June 2023, a new system for central attacking the validity of and thereby to nullify a European Patent has been introduced. If a European patent of concern is an EU Unitary Patent, or if a classically validated European patent was not opted out from the competence of the UPC, a central revocation action under the UPC now exists in parallel to an opposition before the European Patent Office (EPO). Therefore, the question arises: what are the pros and cons of challenging the validity either before the EPO or before the UPC? The present report provides some guidance and discusses the main advantages and disadvantages of each system – which eventually is a matter of strategic considerations whether and which advantage may prevail – be it costs, timing, speed of proceedings, and possibly other issues.
記事へ

Dr Dorothea Hofer has obtained the European Patent Litigation Certificate

We are delighted to announce that our managing partner Dr. Dorothea Hofer has obtained the European Patent Litigation Certificate issued by the University of Maastricht in cooperation with the Academy of European Law (ERA) in Trier. This includes an extensive practical and theoretical training in the law underlying the Unified Patent Court (#UPC) and related fields of European law so that she is well prepared for representing clients in all proceedings before the Unified Patent Court.
記事へ

Chances and Risks of the New European Unitary Patentand New Unified Patent Court – Part 3

Opposition proceedings before the European Patent Office (EPO) are an attractive forum for challenging patents; the procedure is virtually unrivaled worldwide in terms of value for money. The process is simple, streamlined and relatively inexpensive. The practice is well tested. However, there are restrictions and drawbacks – for example, a deadline of nine months after the grant date for submission, the long duration of the opposition and appeal proceedings, and strict rules for admitting evidence submitted late.
記事へ

Chances and Risks of the New European Unitary Patentand New Unified Patent Court – Part 2

During a seven-years transition phase, the jurisdiction of the future Unified Patent Court (UPC) can be declared inapplicable, by way of an opt-out request by the IP right holder, to a pending European patent application (“EP application”), to a granted European patent (“EP”), or to a supplementary protection certificate (“SPC”). This possibility was introduced to build confidence by users on the long run. If opted-out, disputes will then continue to be handled by national courts on a country-by-country basis. Once a European patent has been opted out, it is excluded from the jurisdiction of the UPC for its entire life.
記事へ

Chances and Risks of the New European Unitary Patentand New Unified Patent Court – Part 1

June 1, 2023 marks the beginning of a new era in European patent law: the new European Unitary Patent system entered into force, consisting of the Unitary Patent (UP) and the Unified Patent Court (UPC). 50 years after the introduction of the European Patent Convention and millions of European patents filed, this may be the most prominent change in European patent practice. The Unitary Patent adds as a third pillar to the classical European patents and the national patents. The Unified Patent Court will have an influence on both the unitary patent and the classical European patents as a modern and efficient litigation system.
記事へ

The Unified Patent Court will start on June 1, 2023

Years of planning finally become reality: The official starting signal has now been given! Germany ratified the Agreement on a Unified Patent Court (UPC) on February 17, 2023.
記事へ

Start of the Sunrise Period for Filing Opt-out Requests with the Unified Patent Court on March 1, 2023

According to the current schedule, the Unified Patent Court will start its work on June 1, 2023. The so-called sunrise period, during which opt-out requests can be filed with the Unified Patent Court for granted European patents or published European patent applications will start on March 1, 2023, according to the current planning of the Unified Patent Court.
記事へ

All good things are worth waiting for

“All good things are worth waiting for”. Now the time has finally come: The Unified Patent Court has announced on its website that it plans to commence operations on April 1, 2023.
記事へ

Roadmap and preparations for the EU Unitary Patent and EU Patent Court System

As previously reported, following ratification in Germany, the way is cleared for the European patent with unitary effect (EU unitary patent) and the Unified Patent Court (UPC). As a result of the deposit of the instrument of ratification by Austria on 18 January 2022, the “provisional application of the EPC/UPC” has now entered into force.
記事へ

(I) Introduction and Overview

Introduction

June 1, 2023 marks the beginning of a new era in European patent law: the new European Unitary Patent system entered into force, consisting of the Unitary Patent (UP) and the Unified Patent Court (UPC). 50 years after the introduction of the European Patent Convention and millions of European patents filed, this may be the most prominent change in European patent practice. The Unitary Patent adds as a third pillar to the classical European patents and the national patents. The Unified Patent Court will have an influence on both the unitary patent and the classical European patents as a modern and efficient litigation system.

What will be new, what will remain? As the patent landscape in Europe becomes more complex, other relevant questions arise: what strategic decisions need to be made? How should patent applicants and owners adapt their practice, and what impact can be expected when flanking business in Europe by patent-protected innovation? This article is intended to provide guidance in answering such and other questions and, where appropriate, to draw a comparison with the established German/European litigation regime.

Key points of the new Unified Patent (UP) and Unified Patent Court (UPC) system

Type of protection

With the introduction of the new legal framework, the patent applicant at the European level (i.e. besides the national patents) has the possibility to choose between

(a) the new European patent with unitary effect (“unitary patent” / UP) in the territories of all participating EU member states which have ratified the Unified Patent Court Agreement (UPCA), and

(b) as before, the “classical” European patent, which is a bundle patent and, after grant of the patent, is divided into national parts for the ultimately desired validated countries. If additional protection is sought for individual countries not covered by the unitary patent according to (a) (e.g. the non-EU countries Great Britain or Switzerland), a mixture of (a) and (b) need to be chosen.

The option to choose will be exercised at the time of grant, within a period of 1 month after the publication of the grant. Until grant, the procedure before the European Patent Office is the same, independent of the later choice of the type of protection. This means that the formal, procedural, and substantive requirements are the same, regardless of whether a unitary patent or a classically validated patent is concerned.

Currently, the EU member states shown in the map of Fig. 1 and listed below are covered by the new European patent with unitary effect:

Germany, France, Italy, Austria, Portugal, Netherlands, Belgium, Luxembourg, Austria, Slovenia, Denmark, Sweden, Finland, Estonia, Latvia, Lithuania and Bulgaria


The map on the right shows the respective status of the EU states, depending on whether the UPCA is effective for them (dark blue), whether they have signed the Convention signed but not yet ratified the ratified the treaty (medium blue), or have not signed the treaty (light blue).

It remains to be seen whether the remaining EU member states which have signed but not yet ratified will do so and will ratify the UPCA, and whether Spain, Poland and Croatia, which have so far not acceded to the UPC, will change their position in the future in order to ultimately help the European Unitary Patent system achieve a full EU-wide unitary regime.

Interaction between EPO/EPC and UP/UPC

Up to the grant stage of a European Patent Application, everything remains the same as before. In particular, the European Patent Office (EPO) will remain competent for search and examination. Only at the grant stage the Applicant can choose between a classical validation or a UP, or a mixture of both (UP and validation in countries not party to the UPCA). Opposition before the EPO will remain to exist, no matter whether a UP and/or classical validated EP patent is involved.

The newly introduced Unified Patent Court (UPC) is a common court of the participating EU Member States and contracting states of the UPCA. An important difference to the type of protection is that the UPC has jurisdiction not only over unitary patents but also over classical European patents which have been validated in one or more states, provided that the classical EP patent is not opted out (as discussed later) and the validated country is also an UPCA state. The most significant change for litigation practice is that a decision of the UPC has uniform effect in all participating EU member states.

If the patent applicant chooses the UP as the type of protection at the time of grant, the UPC is mandatory in the participating EU countries. For classical European patents, however, the patent proprietor has the possibility during a 7-year transitional period to exclude the applicability of the UPC by a so-called “opt-out” request; then the old system of national litigation rules remains applicable.

Table 1 summarizes the tasks and competences between EPO and UPC

European Patent Office Unified Patent Court*
Filing

Examination

Grant

Opposition

Appeal

Unitary Patent (UP) Infringement Action
(PI and main proceedings)Declaratory Action of Non-infringementNullity/Revocation Action
validated EP patent*

* the UPC has competence also for classical validated EP patent, unless opted out

Table 2 lists pros and cons for choosing either UP or validation of the EP patent in individual countries. The patent owner’s decision for the one or the other system includes a weighing of pros and cons depending on the individual case.

Pro Contra
 

 

Unitary Patent (UP)

unitary protection in the whole territory of UPCA countries

more simple administration

less annuity fee compared to a total of sum of 4 or more countries

enforcement in 1 efficient UPC court proceedings

harmonized substantive and procedural law

validation of patent in non-UPCA states is still needed if scope of UP territory is not sufficient

during transition phase a complete translation of the patent specification into one other EU language is needed

all or none in terms of maintenance (annuity payments) and validity (risk of total nullity)

 

validated EP patent

still cost-efficient if number of desired countries is relatively low (1 to 3)

abandonment of individual countries while maintaining others is possible (cost factor)

More administrative burden

enforcement in every country needed where infringement takes place

 

Further positive or critical effects will become apparent below when details of the new system and factors to opt into or out of the new law will be discussed.

Procedural law in the new Unified Patent Court (UPC)

The rules of procedure of the Unified Patent Court are similar to the basic structures and procedures of German court proceedings. However, there are special features in the UPC which should be taken care of:

  • The German bifurcated procedure, in which different courts decide on infringement (patent litigation chambers of the competent civil courts) on the one hand and on validity (Federal Patent Court) on the other, does not exist in this strictly separate form. The UPC is basically competent for both proceedings. However, alternatively a local chamber in the infringement action, if a defendant raises a counterclaim against validity, may optionally refer this point to the then competent central chamber.
  • The action for revocation of the patent in the UPC area can also be filed if opposition/appeal proceedings before the EPO are still pending; in the current German law, this is not permitted for classical European patents.
  • Between the written procedure and the oral proceedings, a so-called intermediate procedure is optionally inserted, in which the rapporteur (the judge working on the case) is to clarify all relevant points, questions and evidence and make preparations for the final oral proceedings. The rapporteur may also hold an interim hearing in this interim procedure, usually by telephone or video conference. This interim procedure will go deeper and become more substantial than a mere first hearing under German procedural law.
  • The interim hearing and the oral proceedings (including the examination of witnesses) will be recorded.
  • Testimony as admissible evidence requires a written statement and, by order of the court or at the request of the party offering the testimony, an oral examination of the witness.
  • The final decision will usually be announced already at the end of the final hearing; the written statement of reasons for the decision shall be set forth by the court within 6 weeks after the hearing.
  • Decisions and orders of the court shall be published; under certain circumstances, pleadings and evidence may also be publicly available upon reasoned request.
  • The procedure before the UPC is scheduled to proceed quickly; per instance a decision is to be expected within 12-14 months – much faster than national proceedings and EPO oppositions.
  • To enable such quick proceedings, the parties’ timelines are correspondingly short: response due dates of only 3 months (re infringement) or 2 months (re nullity) require fast and diligent parties’ preparations of their facts and arguments.
  • Besides these main proceedings, effective preliminary injunctions (PIs) are possible. As defence options, potential defendants may take precautionary measures by filing protective letters – which may deal with non-infringement and invalidity arguments – in advance of any potential PI; the protective letter is communicated to the Patent Proprietor not before a PI is filed. While protective letters are also allowed in Germany, this is not the case in national practices of some other countries.
  • English as court language is generally permitted in UPC proceedings, including the German local and central divisions.

Thus, it is clear that while the patent landscape and litigation in Europe will be made more complex by the new European Unitary Patent and the new Unified Patent Court, these instruments effectively open up additional means and ways of a centralized, effective and relatively inexpensive system for obtaining and enforcing rights. However, achieving the strategic goals will require more than ever good preparation and attention to the peculiarities and tight time regime in the new litigation law.

Further to Part 2: (II) Strategic Considerations of using the new EU Court, or Opting out

Further to Part 3: (III) Comparison of Opposition Proceedings at the EPO and Nullity Proceedings at the UPC

 

Other UPC-Updates

UPCから見たクレーム解釈、事実の開示と立証の責任 – UPC_CoA_335/2023

UPCの最初の判決が下された。クレーム解釈、事実の開示と立証の責任、さらに進歩性の検討など、多くの議論がなされている問題に関するUPCの立場を知ることは、エキサイティングなことである。
記事へ

Comparison of opposition proceedings at the EPO and revocation actions at the UPC – advantages and disadvantages

Since the introduction of the Unified Patent Court (UPC) in June 2023, a new system for central attacking the validity of and thereby to nullify a European Patent has been introduced. If a European patent of concern is an EU Unitary Patent, or if a classically validated European patent was not opted out from the competence of the UPC, a central revocation action under the UPC now exists in parallel to an opposition before the European Patent Office (EPO). Therefore, the question arises: what are the pros and cons of challenging the validity either before the EPO or before the UPC? The present report provides some guidance and discusses the main advantages and disadvantages of each system – which eventually is a matter of strategic considerations whether and which advantage may prevail – be it costs, timing, speed of proceedings, and possibly other issues.
記事へ

Dr Dorothea Hofer has obtained the European Patent Litigation Certificate

We are delighted to announce that our managing partner Dr. Dorothea Hofer has obtained the European Patent Litigation Certificate issued by the University of Maastricht in cooperation with the Academy of European Law (ERA) in Trier. This includes an extensive practical and theoretical training in the law underlying the Unified Patent Court (#UPC) and related fields of European law so that she is well prepared for representing clients in all proceedings before the Unified Patent Court.
記事へ

Chances and Risks of the New European Unitary Patentand New Unified Patent Court – Part 3

Opposition proceedings before the European Patent Office (EPO) are an attractive forum for challenging patents; the procedure is virtually unrivaled worldwide in terms of value for money. The process is simple, streamlined and relatively inexpensive. The practice is well tested. However, there are restrictions and drawbacks – for example, a deadline of nine months after the grant date for submission, the long duration of the opposition and appeal proceedings, and strict rules for admitting evidence submitted late.
記事へ

Chances and Risks of the New European Unitary Patentand New Unified Patent Court – Part 2

During a seven-years transition phase, the jurisdiction of the future Unified Patent Court (UPC) can be declared inapplicable, by way of an opt-out request by the IP right holder, to a pending European patent application (“EP application”), to a granted European patent (“EP”), or to a supplementary protection certificate (“SPC”). This possibility was introduced to build confidence by users on the long run. If opted-out, disputes will then continue to be handled by national courts on a country-by-country basis. Once a European patent has been opted out, it is excluded from the jurisdiction of the UPC for its entire life.
記事へ

Chances and Risks of the New European Unitary Patentand New Unified Patent Court – Part 1

June 1, 2023 marks the beginning of a new era in European patent law: the new European Unitary Patent system entered into force, consisting of the Unitary Patent (UP) and the Unified Patent Court (UPC). 50 years after the introduction of the European Patent Convention and millions of European patents filed, this may be the most prominent change in European patent practice. The Unitary Patent adds as a third pillar to the classical European patents and the national patents. The Unified Patent Court will have an influence on both the unitary patent and the classical European patents as a modern and efficient litigation system.
記事へ

The Unified Patent Court will start on June 1, 2023

Years of planning finally become reality: The official starting signal has now been given! Germany ratified the Agreement on a Unified Patent Court (UPC) on February 17, 2023.
記事へ

Start of the Sunrise Period for Filing Opt-out Requests with the Unified Patent Court on March 1, 2023

According to the current schedule, the Unified Patent Court will start its work on June 1, 2023. The so-called sunrise period, during which opt-out requests can be filed with the Unified Patent Court for granted European patents or published European patent applications will start on March 1, 2023, according to the current planning of the Unified Patent Court.
記事へ

All good things are worth waiting for

“All good things are worth waiting for”. Now the time has finally come: The Unified Patent Court has announced on its website that it plans to commence operations on April 1, 2023.
記事へ

Roadmap and preparations for the EU Unitary Patent and EU Patent Court System

As previously reported, following ratification in Germany, the way is cleared for the European patent with unitary effect (EU unitary patent) and the Unified Patent Court (UPC). As a result of the deposit of the instrument of ratification by Austria on 18 January 2022, the “provisional application of the EPC/UPC” has now entered into force.
記事へ

We are pleased to share that our firm Prüfer & Partner together with four of our intellectual property attorneys have been recognized for their outstanding work in patent prosecution and nullity in the newly published 2023 Edition of iam Patent 1000, one of the world’s leading rankings with regard to patent services providers.

What the ranking said
Prüfer & Partner
“The attorneys at Prüfer & Partner stand out from their peers for their thoughtful consideration of the position of the client. They are always responsive and provide detailed and pragmatic solutions. Their service is very satisfactory and the whole team is highly recommended.”

Jürgen Feldmeier
“Jürgen Feldmeier is an experienced, go-to patent attorney in the field of high-tech engineering, and is highly appreciated for his clear-cut advice. He handles EPO proceedings and nullity actions with ease – typically with a successful result. He is great to cooperate with and he has sharp technical understanding.”

Dr. Dorothea Hofer
“Dorothea Hofer is excellent. She delivers great service, responds quickly and appropriately, and she has a strong ability to understand complicated technical matters. She appropriately selects her associates to form a solid team to handle important cases like litigation cases. The quality and cost effectiveness of her work is totally satisfactory. Dorothea and her firm are among the most recommendable patent experts in Germany.”

Dr. Andreas Oser
“For prosecution, EPO oppositions and technically informed opinions, Andreas Oser is definitely recommended. He is reliable and brings deep experience in the field. He is customer oriented and very nice to work with.”

Markus Adamczyk
Joining the above-mentioned attorneys in the IAM Patent 1000 this year is Markus Adamczyk, a noted expert in AI and computer-implemented inventions. With skills in computer science and mechanical engineering, and research experience in-house at Vodafone, Adamczyk’s technical expertise cannot be doubted. He supports Feldmeier for printing industry leader Brother Industries and special machinery and plant engineering company Hymmen GmbH.

About IAM Patent 1000
The prestigious ranking IAM Patent 1000, published by Globe Business Media Group in London, is commonly regarded as the definitive ‘go-to’ resource for those seeking to identify world-class, private practice patent expertise as well as leading patent service providers. IAM undertook an exhaustive qualitative research project to identify outstanding firms and individuals across multiple jurisdictions. When identifying the leading firms, factors such as depth of knowledge, market presence, and the level of work on which they are typically instructed were all taken into account, as well as positive peer and client feedback.

We are very pleased that our patent attorneys Dr. Dorothea Hofer, Mr. Jürgen Feldmeier as well as Dr. Andreas Oser are listed as beste Anwälte des Jahres 2023 (best attorneys of the year 2023) in the ranking published by Handelsblatt on June 16, 2023.

It is a great honor for our firm that three of our experts are represented in this prestigious ranking. We would like to thank our colleagues for the numerous recommendations and the good cooperation!

We look forward to continuing to provide our clients with the best possible support in all intellectual property matters and to protect their rights.

About the Best Lawyers ranking by Handelsblatt
In cooperation with the US publishing House Best Lawyers, the renowned business magazine Handelsblatt has determined the well-known ranking of the best lawyers and business law firms in Germany for the year 2023. The current edition in Handelsblatt is based on the 15th edition of the Best Lawyers rating.

In the procedure, lawyers are asked which competitors they can particularly recommend. The selection procedure follows the conviction that lawyers themselves are best able to judge which colleagues are particularly qualified for certain areas of law. Lawyers can be nominated by anyone except themselves.

According to the current schedule, the Unified Patent Court will start its work on June 1, 2023.

The so-called sunrise period, during which opt-out requests can be filed with the Unified Patent Court for granted European patents or published European patent applications will start on March 1, 2023, according to the current planning of the Unified Patent Court.

An opt-out request is only effective if it is entered in the register of the Unified Patent Court.

At present, it is not yet known how long it will take from filing the opt-out request to registration, as there are no empirical values yet. In a test phase for the file management and communication software of the Unified Patent Court, which will start on February 13, 2023, we will be able to test the process of filing the request, but this does not allow us to draw any firm conclusions on the subsequent processing time of opt-out requests at the Unified Patent Court.

We therefore recommend filing any opt-out requests as early as possible starting from March 1, 2023.

Now is the time to review again your patent portfolio of European patents and published European patent applications and to decide for which patents/patent applications an opt-out request should be filed early.

Do you have any further questions on this topic or on the Unified Patent Court and the Patent with Unitary Effect?

Please do not hesitate to contact us, we will be happy to advise you!

Obtain Information

Dr. Dorothea Hofer
European and German Patent, Trademark and Design Attorney

This article was originally published in German on JUVE Handbuch Wirtschaftskanzleien 2022/2023.

The decision of the Enlarged Board of Appeal (GBK) of the European Patent Office (EPO) in the currently pending proceedings G2/21 is awaited with great excitement. This could have a significant impact on the future filing strategy of applicants, because at its core is the question of when an invention is “ready” to file.

Securing an early filing date for an invention is an important aspect of a patent strategy in order to secure one’s own legal position vis-à-vis competitors. For time and cost reasons, the question arises as to how much experimental effort must be expended under patent law aspects before filing a patent application in order to support the claimed effects, or whether corresponding evidence can be submitted subsequently.

Until a decision G2/21 is issued to finally clarify relevant submission questions, this article will discuss practical scenarios that will continue to exist regardless of the answer to the referred questions, but will have to be – possibly re – evaluated with the help of decision G2/21.

Suitability of “evidence” from product development as support of an invention

In the context of a product development, the product of a competitor or the internal ‘gold standard’ is often used as a reference product, regardless of whether the structure or composition of this reference product is known precisely. Such comparative data are often not usable in the context of the ‘problem-solution approach’ applied by the EPO, since, according to established case law, the claimed effect must be clearly attributable to the distinguishing characteristic.

Experimentally investigating the influence of all potentially relevant parameters on the claimed effect and thus exploring the limits of the invention can be time-consuming and financially expensive and usually does not appear to be expedient from the inventor’s point of view.

Irrespective of this, the proof of technical effects can often only be produced with pinpoint accuracy in the knowledge of the objectively closest prior art, e.g. in the examination procedure, since only then will the objectively fitting (because closest to the claimed invention) comparative form be known.

For such reasons, experimental investigations are often postponed to a later point in time. Whether this postponement is possible at all, however, is now to be clarified by the GBK.

Underlying question of G2/21

According to the questions referred, the GBK is primarily concerned with the question of whether evidence such as experimental data must be disregarded only after the patent application has been filed if it constitutes the exclusive evidence for a claimed effect. Three approaches are presented to the GBK, all of which revolve around the criterion of whether or to what extent the information originally provided in the application must render a claimed effect plausible:

The most generous scenario for the applicant would be if the exclusive evidence for a claimed effect could readily be provided after the filing date, i.e., no plausibility requirement at all. This would allow filing an invention in an early, possibly speculative (“immature”) state to secure an early filing date.

However, should the GKB come to the conclusion that minimum plausibility requirements are to be set with regard to the claimed effects in the application itself, a corresponding “ab-initio plausibility” could be applied as a standard for the technical effects.

In a third case, it could be required as a minimum that the claimed effects are at least not implausible from the outset, i.e. that there is no “ab-initio implausibility“.

State of maturity – when is an invention ready to be submitted

Regardless of how the GBK will decide, we always consider it useful to file an application only when advantages over the prior art can at least be named; proof of the technical effects, e.g. by comparative experiments, should be checked before filing.

The “state of maturity” of an invention could be classified as follows:

(i) effects are not (yet) known, only the features characterizing the desired product can be stated.

In this case, if an early filing date is a priority, one could include a “laundry list” of potential effects in the application text, and then pick the desired effect if needed. Although a lack of disclosure does not arise directly from the failure to obtain effects from the application as long as they are not reflected in the claim wording, an entirely speculative invention description could, in some circumstances, call into question the consideration of late evidence or even reworkability.

(ii) Effects are expected and the features of the invention that are causally responsible are suspected.

Here, the expected effects can already be specifically named; these should then at least not be “ab-initio implausible”. From a technical point of view, no doubts should be justified against the possible achievement of the named effects. In the description of the invention in the original application, the challenge is that it is not known which features/parameters are causal for the achievement of the effect. Regardless of decision G2/21, if possible, the “causality” between effects and the corresponding features of the invention should be investigated and explained in the application text. Previously published literature can help to substantiate this causal relationship. Patent law only requires that something works or that a set task is solved; a scientific explanation of how a claimed problem solution works is not necessarily required.

(iii) Effects are expected, it can be concluded on the basis of technical considerations which features of the invention should be causally responsible for them.

A technical explanation that the claimed effects are expected can be given in the patent application (“ab-initio plausibility”). However, a real experimental proof is still missing. In such a case, the prospects of grant – assuming the required novelty – are likely to be good, but it is to be expected that e.g. in possible opposition proceedings the opposing party could attack this “plausibility”, e.g. by submitting reasonable doubts that the theory underlying the plausibility is not correct. Without wanting to anticipate the final decision in the current referral G2/21, however, it should be possible in these case constellations on the basis of the existing “ab initio plausibility” to substantiate the expected technical effects in the factual instance – i.e. not only in appeal or appeal – by means of subsequently supplied experiments and data.

(iv) Effects are known and proven

Here, there should be nothing to argue against filing a patent application. If new prior art is invoked, e.g. in the examination procedure, it should be possible to provide further (post-published) experimental data to support the effects already shown in the application, if required.

Special cases

Special cases exist if technical effects are only proven or expected for a part of a claimed subject-matter, or if a technical effect itself constitutes a claimed feature – e.g. in a use claim. In the first case, the question then arises whether the technical effect can plausibly be generalized to the remaining part of the claim, and in the second case the criterion of “plausibility” will also be relevant in the context of examining whether the invention is sufficiently disclosed at all and thus practicable. Here, too, however, considerations similar to those explained earlier should play a role.

Conclusion

• The decision of the GBK in the proceedings G2/21 will hopefully provide clarity as to the “state of maturity” in which an invention must be filed in order for claimed effects to be recognized.
• In many cases, regardless of the standard to be applied under G2/21, early submission will be desired.
• It is already apparent that the question of “plausibility” does not constitute a patenting requirement in its own right, but is an important criterion in the examination for inventive step and possibly even the practicability of a claimed invention.
• In any case, it is wise to check the maturity of the invention before filing a patent application in order to achieve the best possible result and obtain a strong patent.

Authors:

Dr. Susanne Sonnenhauser
Ms. Sonnenhauser has been working in the field of intellectual property since 2005 and is admitted as a German Patent Attorney and European Patent Attorney. She joined Prüfer & Partner in 2008.

Her main practice areas are patent and trademark law, mainly in the fields of pharmaceuticals and life science.
Ms. Sonnenhauser represents her clients in both patent grant and opposition proceedings. In addition, she provides expert opinions regarding the validity and infringement of intellectual property rights.

Dr. Andreas Oser, LL.M.
Andreas Oser (Dipl.-Chem. University of Freiburg; Ph.D. Max-Planck-Institute for Biochemistry Munich) has been working in the field of intellectual property since 1991, was admitted as a German and European patent attorney in 1995 and has been a managing partner at Prüfer & Partner since 2002.

Mr. Oser’s main areas of expertise are chemistry, pharmaceuticals and life science.

His practice includes patent prosecution (drafting, examination), opposition and appeal proceedings, patent litigation, infringement and validity opinions, freedom-to-operate analyses and due diligence examinations.

Contact:
Prüfer & Partner mbB
Sohnckestrasse 12, 81479 München
Tel. +49 89 69 39 21 0, E-Mail office@pruefer.eu, www.pruefer.eu